{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:06:35Z","timestamp":1770271595300,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jbo.2022.100413","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:23:18Z","timestamp":1643451798000},"page":"100413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["FGF-23 transmitted tumor \u2013 induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-5727","authenticated-orcid":false,"given":"Florian A.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Baumhoer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2022.100413_b0005","first-page":"554","article-title":"Rickets following bone tumor","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Paediatr Acta"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.jbo.2022.100413_b0015","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jbo.2022.100413_b0020","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2022.100413_b0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","article-title":"Reports of 17 Chinese patients with tumor-induced osteomalacia","volume":"35","author":"Yu","year":"2017","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"10.1016\/j.jbo.2022.100413_b0030","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.jbo.2022.100413_b0035","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4158\/EP.14.9.1108","volume":"14","author":"Habra","year":"2008","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.jbo.2022.100413_b0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","article-title":"The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23","volume":"27","author":"White","year":"2006","journal-title":"Endocr Rev"},{"issue":"Suppl 3","key":"10.1016\/j.jbo.2022.100413_b0045","first-page":"342","article-title":"Renal phosphate\u2013wasting disorders in childhood","volume":"2","author":"Ward","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"10.1016\/j.jbo.2022.100413_b0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","article-title":"Tumor-induced osteomalacia","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"10.1016\/j.jbo.2022.100413_b0055","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.12426","article-title":"Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients","volume":"81","author":"Jadhav","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jbo.2022.100413_b0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jbo.2022.100413_b0070","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1007\/s00330-020-07342-2","article-title":"Diagnostic efficiency of (68)Ga-DOTANOC PET\/CT in patients with suspected tumour-induced osteomalacia","volume":"31","author":"He","year":"2021","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.jbo.2022.100413_b0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jbo.2022.100413_b0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00259-018-3971-x","article-title":"Diagnostic performance and impact on patient management of (68)Ga-DOTA-TOC PET\/CT for detecting osteomalacia-associated tumours","volume":"45","author":"Paquet","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02405074","article-title":"Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets","volume":"35","author":"Marie","year":"1983","journal-title":"Calcif Tissue Int"},{"issue":"17","key":"10.1016\/j.jbo.2022.100413_b0090","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.1998.00718.x","article-title":"X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations","volume":"53","author":"Scheinman","year":"1998","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jbo.2022.100413_b0100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0105","first-page":"33","article-title":"Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"Mc","year":"1947","journal-title":"Q J Med"},{"key":"10.1016\/j.jbo.2022.100413_b0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222851","article-title":"Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration","volume":"2018","author":"Klein","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.jbo.2022.100413_b0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1016\/j.jbo.2022.100413_b0120","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Santa Cruz, Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2022.100413_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/ar.2014.5.0100","article-title":"Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review","volume":"5","author":"Deep","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00467-014-2979-0","article-title":"Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature","volume":"30","author":"Burckhardt","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.jbo.2022.100413_b0135","first-page":"205","article-title":"Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia \u2013 diagnostic challenges and clinical outcomes","volume":"69","author":"Dutta","year":"2018","journal-title":"Endokrynol Pol"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s100240050008","article-title":"Phosphaturic mesenchymal tumor-induced rickets","volume":"3","author":"Reyes-M\u00fagica","year":"2000","journal-title":"Pediatr Dev Pathol"},{"issue":"12","key":"10.1016\/j.jbo.2022.100413_b0145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMcpc010029","article-title":"Case 29-2001: A 14-Year-Old Boy with Abnormal Bones and a Sacral Mass","volume":"345","author":"Cabot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbo.2022.100413_b0150","doi-asserted-by":"crossref","first-page":"3176978","DOI":"10.1155\/2016\/3176978","article-title":"Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease","volume":"2016","author":"Hu","year":"2016","journal-title":"Dis Markers"},{"issue":"10","key":"10.1016\/j.jbo.2022.100413_b0155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ncpendmet0639","article-title":"Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels","volume":"3","author":"Halperin","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jbo.2022.100413_b0160","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","author":"Ledford","year":"2013","journal-title":"Clin Orthop Relat Res"},{"issue":"9308","key":"10.1016\/j.jbo.2022.100413_b0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"de Beur","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jbo.2022.100413_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","article-title":"Tumor-induced osteomalacia: a single center experience","volume":"17","author":"Jagtap","year":"2011","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.jbo.2022.100413_b0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","article-title":"Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia","volume":"268","author":"Ito","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.jbo.2022.100413_b0180","article-title":"Selective blood sampling for FGF-23 in tumor-induced osteomalacia","volume":"2017","author":"Schober","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.jbo.2022.100413_b0185","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.jbo.2022.100413_b0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia","volume":"40","author":"Zhang","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jbo.2022.100413_b0195","article-title":"Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET\/CT, venous sampling and 3T-MRI","volume":"2017","author":"Kawai","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.jbo.2022.100413_b0200","doi-asserted-by":"crossref","unstructured":"K.L. Insogna, K. Briot, E.A. Imel, P. Kamenicky, M.D. Ruppe, A.A. Portale, T. Weber, P. Pitukcheewanont, H.I. Cheong, S. Jan de Beur, Y. Imanishi, N. Ito, R.H. Lachmann, H. Tanaka, F. Perwad, L. Zhang, C.Y. Chen, C. Theodore-Oklota, M. Mealiffe, J. San Martin, T.O. Carpenter, A. Investigators, A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res. 33(8). (2018). 1383-1393.","DOI":"10.1002\/jbmr.3475"},{"issue":"4","key":"10.1016\/j.jbo.2022.100413_b0205","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jbo.2022.100413_b0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the Treatment of Tumor-Induced Osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jbo.2022.100413_b0215","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/jbmr.4317","article-title":"Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:19:38Z","timestamp":1761941978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137422000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":43,"alternative-id":["S2212137422000033"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100413","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF-23 transmitted tumor \u2013 induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100413"}}